Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect a strong consensus on the importance of sdLDL as the most atherogenic lipoprotein, with posts referencing recent research, emphasizing the potential for improved risk assessment, and debating the relevance of traditional markers. The tone and choice of words like 'most atherogenic,' 'significant,' and 'impactful' demonstrate enthusiasm and recognition of the study's potential to influence future clinical practices.
Most discussions agree that the study highlights sdLDL as a key predictor of cardiovascular risk, emphasizing its significance in medical research and practice.
The social discussions demonstrate high interest, with many referencing recent studies, debates over traditional markers, and potential therapies, showing engagement with the research topic.
Participants analyze the implications, compare it with other lipoprotein parameters, and cite multiple studies, indicating deep engagement with the scientific content.
There's a consensus that the findings could influence future diagnostic and treatment approaches, suggesting a high potential impact on cardiovascular risk assessment.
Estudio prospectivo de Framingham La partícula lipídica mas aterogénica es LDL pequeña y densa LDL/TG es otro parámetro importante LDL medición directa, se relaciona mucho menos (seguro que incluye L5 y LDL desialisado, no se estudió) LDL grande NO https://t.co/SsngYaUSN7 https://t.co/xhUMssyl9w
Another in 2021 ...https://t.co/hmDwTA5V83
“Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.” https://t.co/UZu8sGx4hr
Small dense low-density lipoprotein cholesterol is the laboratory parameter most strongly associated with heart disease. https://t.co/ga2UDFrvRo @Eschaefer1945 #AHAJournals https://t.co/Us2VZyV6Kw
"Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter. . . In our view, sdLDL is substantially more atherogenic than lbLDL because of its smaller size and its greater plasma residence time" - https://t.co/JHbkkGZAm0
https://t.co/eJ1CRUpaHE
Explore saturated fat on keto and how much is enough. We examine potential benefits and risks, with insights from recent studies on cholesterol's impact on heart health.
This video discusses the significance of small dense LDL cholesterol as the most atherogenic lipoprotein parameter, based on the Framingham Offspring Study, emphasizing its impact on cardiovascular health.
This video examines the evidence surrounding low-fat diets recommended by health agencies. It discusses characteristics, potential benefits, and challenges faced with such diets, while also highlighting insights from…
@Stellaster27074 @MohammedAlo https://t.co/QpDvW80Mi2
@Lipoprotein Respectfully Dr Cromwell, some recent papers from Krauss, Ballantyne & Schaeffer to represent some counter-arguments to your position and some recent evidence on sdLDL: https://t.co/gsbTdbjUuF https://t.co/zJZVyndzyu https://t.co/fIYT4aVpIi https://t.co/cZB91ezCWy https://t.co/iJS1ZDdbBL
https://t.co/eJ1CRUpaHE
@GMuelMuel @Absurd_Stoic @tednaiman I would suggest reading the post! Framingham also showed that apoB was no better than the TC/HDL ratio. And LDL-P is a mix of lipoproteins, with the risk in Framingham Offspring best associated with smaller LDLs. https://t.co/r8xfXV3i5H https://t.co/8QcFvujswe
@drjkahn @LeeGarcia85 @LDLSkeptic @PeterAttiaMD @ethanjweiss @ProfTimNoakes @KenDBerryMD @lowcarbGP @ifixhearts @DrPascalMeier Dr Kahn, In your recent podcast, you talked about advantages of Berberine, Kyolic having similar reduction of plaque like statin. Would they be better than statin? Per this studWould these natural agents be more successful in reducing small LDL-P? https://t.co/L2KSwFdMh3
@drjkahn @Cutter1616 Then why @IvorCummins is anti Statin/LDL? You both avoided that topic. :) Cardiologists like Dr Aseem M, Nadir Ali , Bret Scher, and 100+ MDs,PhDs are opposed... https://t.co/TLS6UNkOy6 Think small LDL-P is the culprit... Thoughts? https://t.co/qvGggVfuhb
RT @lipo_fan: https://t.co/pv34NkA0Tv
https://t.co/pv34NkA0Tv
@PavlicaDanijel @CRYPT0N1TE @FusionProgGuy @robertlufkinmd @fproofmastery @theproof @NutritionMadeS3 @Drlipid @MohammedAlo @Paddy_Barrett I guess this would be some evidence?
Another in 2021 ...https://t.co/hmDwTA5V83
@NutritionMadeS3 In your Dr. Berg video why do you rely on a 2003 study to dismiss the claim that Small density LDL is relevant? Following your do your own research advice I see numerous more recent scientific backup for the proposition, here's one: https://t.co/j3T8b1F24P
@PeterAttiaMD @mcgillu Curious about link between apoB and sdLDL as used here: https://t.co/OKtQBSb3rt.
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Framingham Heart Study #IOnlyReadTheAbstract https://t.co/81MP4nowNT
Is sdLDL-C the most atherogenic type of lipoprotein? Having discordantly high sdLDL-C compared to non-HDL-C increased CVD risk ~30% after adjusting for multiple risk factors. https://t.co/thnqnjAvWz https://t.co/s0BWmpiCcG
@LaEstanciaVilla Thank you for the heads up. Will retweet with correct link. https://t.co/thnqnjAvWz
Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study https://t.co/IlT99uhurk
“sdLDL‐C, direct LDL‐C, and lipoprotein(a) all contributed significantly to ASCVD risk…but no parameter added significant risk information…once sdLDL‐C was in the model. …small dense LDL is the most atherogenic lipoprotein parameter.” https://t.co/xm3qGMqpL8
RT @DiscoStew66: “Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.” https://t.co/UZu8sGx4hr
RT @DiscoStew66: “Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.” https://t.co/UZu8sGx4hr
“Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.” https://t.co/UZu8sGx4hr
RT @rogercorder: @CotsCardiology @mmamas1973 @pnatarajanmd @DBelardoMD @purviparwani @DrScottMurray @FatEmperor @DrAseemMalhotra @KoffmannP…
@CotsCardiology @mmamas1973 @pnatarajanmd @DBelardoMD @purviparwani @DrScottMurray @FatEmperor @DrAseemMalhotra @KoffmannPierre This recent paper might be of interest: https://t.co/Q3nsYoAjr9
RT @JAHA_AHA: Small dense low-density lipoprotein cholesterol is the laboratory parameter most strongly associated with heart disease. http…
RT @JAHA_AHA: Small dense low-density lipoprotein cholesterol is the laboratory parameter most strongly associated with heart disease. http…
Small dense low-density lipoprotein cholesterol is the laboratory parameter most strongly associated with heart disease. https://t.co/ga2UDFrvRo @Eschaefer1945 #AHAJournals https://t.co/Us2VZyV6Kw
Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study @American_Heart https://t.co/WcfGiQ3nDJ
RT @EstebanDL: Estudio prospectivo de Framingham La partícula lipídica mas aterogénica es LDL pequeña y densa LDL/TG es otro parámetro im…
RT @EstebanDL: Estudio prospectivo de Framingham La partícula lipídica mas aterogénica es LDL pequeña y densa LDL/TG es otro parámetro im…
Estudio prospectivo de Framingham La partícula lipídica mas aterogénica es LDL pequeña y densa LDL/TG es otro parámetro importante LDL medición directa, se relaciona mucho menos (seguro que incluye L5 y LDL desialisado, no se estudió) LDL grande NO https://t.co/SsngYaUSN7 https://t.co/xhUMssyl9w
RT @ZahcM: "Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter. . . In our view, sdLDL is substantially m…
"Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter. . . In our view, sdLDL is substantially more atherogenic than lbLDL because of its smaller size and its greater plasma residence time" - https://t.co/JHbkkGZAm0